Recent News
January 05, 2019
Prostate cancer often presents unique challenges to patients and physicians alike. It can be indolent and nonaggressive — or life-threatening and everything in between. Unlike most cancers that have a dedicated road map for treatment, prostate cancer revolves around opinions and biases.What's this item about? What makes it interesting? Write a catchy description to grab your audience's attention...
October 18, 2018
A study published Wednesday in the American Journal of Preventive Medicinecaptured a snapshot of the attitudes black men have regarding prostate cancer research and the evolving field of genomic testing, finding significant mistrust of the healthcare system and medical research.
May 15, 2018
American doctors are successfully persuading increasing numbers of men with low-risk prostate cancer to reject immediate surgery and radiation in favor of surveillance, a trend that is sparing men's sexual health without increasing their risk of death.
Cigna becomes the first US insurer to cover HIFU for prostate cancer
April 18, 2018
Cigna, a global health insurance service company based in the US, announced that patients in the United States who have localized radio-recurrent prostate cancer are potentially eligible for insurance coverage for HIFU treatment.
March 06, 2018
HIFU utilizes ultrasound waves to destroy cancer cells with no damage to surrounding tissue. To date it is not covered by most insurance but the outcomes are quite remarkable and efforts are being made to improve insurance participation. Learn more about HIFU.
January 25, 2018
Phil Chenier was treated for prostate cancer in 2004 and again in 2016, each time based on elevated PSA readings and follow-up exams. Fortunately with regular checkups, he had the benefit of early detection, and on both occasions he had the support from friends familiar with the disease that helped him face this head on.
How One Family Tackled The 'Team Sport' Of Tough Prostate Cancer Choices.
December 15, 2017
While patients with very low-risk prostate cancer may be treated with active surveillance (AS), reducing over-treatment and treatment-related complications, a new study shows that only one in four patients in this group actually opt for this treatment.
October 19, 2017
Androgen-deprivation therapy, which is a common treatment for prostate cancer, has been tentatively linked with an increased risk of cardiovascular disease. A new study solidifies these concerns.
October 13, 2017
Does my choice of initial prostate cancer treatment preclude other treatments later on?
.
May 22, 2017
Fox News takes a look at some of the assumptions that have been made about prostate cancer. It;s important to know the facts. ..
May 17, 2017
Study finds MRI and MRI-guided biopsy cheaper long-term than standard ultrasound.
A diagnostic MRI followed by one of three MRI-guided biopsy strategies is a cost-effective method to detect prostate cancer, according to a new study out of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center.
February 02, 2017
The anxiety many men experience after being diagnosed with prostate cancer may lead them to choose potentially unnecessary treatment options, researchers report.
“Emotional distress may motivate men with low-risk prostate cancer to choose more aggressive treatment, such as choosing surgery over active surveillance,” says the study’s lead author, Heather Orom, associate professor of community health and health behavior in the University at Buffalo’s School of Public Health and Health Professions.
February 01, 2017
Men whose prostate cancer comes back after surgery are more likely to survive if, along with the usual radiation, they also take drugs to block male hormones.
The finding, published Wednesday in The New England Journal of Medicine, comes from a long-running study that experts say will help clarify treatment for many patients.
January 20, 2017
Giving men with suspected prostate cancer an MRI scan could improve diagnosis and save those who do not have aggressive cancers from having an unnecessary biopsy, according to a study published in The Lancet.
The study estimates that adding the extra test could help one in four (27%) men avoid an unnecessary biopsy and reduce the number of men who are over-diagnosed – diagnosed with a cancer that does not go on to cause any harm during their lifetime – by 5%.
October 05, 2016
Men hoping to avoid some side effects of prostate cancer treatment are shelling out tens of thousands of dollars for a procedure whose long-term effects are unknown and insurers, including Medicare, won’t pay for.(continue)
September 15, 2016
The survival rate for early-stage prostate cancer is 99 percent after 10 years, regardless of whether men undergo surgery, radiation or are "actively monitored," according to studies published Wednesday. Researchers hailed the results as good news, saying they had been expecting a survival rate of 90 percent. (continue)
July 19, 2016